Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 360, Issue 6, 1999, Pages 609-615

  Weichel, Oksana ^a   Hilgert, Michael ^a   Chatterjee, Shyam S ^b   Lehr, Matthias ^c   Klein, Jochen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b Section of Pharmacology   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Bilobalide; Choline; Hippocampus; Microdialysis; NMDA; Phospholipase A2

Indexed keywords

BILOBALIDE; CHOLINE; N METHYL DEXTRO ASPARTIC ACID; PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; DEGENERATIVE DISEASE; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVATION; ENZYME INHIBITION; GINKGO BILOBA; HIPPOCAMPUS; HYPERACTIVITY; MALE; MICRODIALYSIS; NERVE CELL; NONHUMAN; PROTEIN TRANSPORT; RAT;

ANIMALS; CELLS, CULTURED; CHOLINE; CYCLOPENTANES; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FURANS; GINKGO BILOBA; GINKGOLIDES; GLYCERYLPHOSPHORYLCHOLINE; GLYCINE; HIPPOCAMPUS; LYSOPHOSPHATIDYLCHOLINES; MALE; MICRODIALYSIS; N-METHYLASPARTATE; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES;

EID: 0033394501     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002109900131     Document Type: Article

References (47)

1. Ahlemeyer B, Möwes A, Krieglstein J (1999) Inhibition of serum deprivation-and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Eur J Pharmacol 367:423-430
2. 2. Annu Rev Pharmacol Toxicol 39:175-189
3. Barbour B, Szatkowski M, Ingledew N, Attwell D (1989) Arachidonic acid induces a prolonged inhibition of glutamate uptake into glial cells. Nature 342:918-920
4. Bars PL le, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. J Am Med Assoc 278:1327-1332
5. Bazan NG Jr (1970) Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain. Biochim Biophys Acta 218:1-10
6. Bazan NG, Rodriguez De Turco EB, Allan G (1995) Mediators of injury in neurotrauma: intracellular signal transduction and gene expression. J Neurotrauma 12:791-814
7. Birkle DL, Kurian P, Braquet P, Bazan NG (1988) Platelet-activating factor antagonist BN52021 decreases accumulation of free polyunsaturated fatty acid in mouse brain during ischemia and electroconvulsive shock. J Neurochem 51:1900-1905
8. Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
9. 2. Nature 390:622-625
10. Danysz W, Parsons CG (1998) Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. Pharmacol Rev 50:597-664
11. DeFeudis FV (1998) Ginkgo biloba extract (EGb761): from chemistry to the clinic. Ullstein Medical, Wiesbaden
12. Dumuis A, Sebben M, Haynes L, Pin J-P, Bockaert J (1988) NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 336:68-70
13. 2 activation influences the processing and secretion of the amyloid precursor protein. Biochem Biophys Res Commun 197:292-297
14. 2 and its role in brain tissue. J Neurochem 69: 889-901
15. Flynn CJ, Wecker L (1987) Concomitant increases in the levels of choline and free fatty acids in rat brain: evidence supporting the seizure-induced hydrolysis of phosphatidylcholine. J Neurochem 48:1178-1184
16. Fourtillan JB, Brisson AM, Girault J, Ingrand I, Decourt JP, Drieu K, Jouenne P, Biber A (1995) Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Gingko biloba extract (EGb 761). Thérapie 50:137-144
17. Hilgert MW, Weichel O, Chatterjee SS, Klein J (1999) Antagonistic action of bilobalide at the N-methyl-D-aspartate receptor: in vivo evidence from microdialysis experiments. Naunyn-Schmiedeberg's Arch Pharmacol 359 [Suppl 3]:R95
18. Ikeda M, Yoshida S, Busto R, Santiso M, Ginsberg MD (1986) Polyphosphoinositides as a probable source of brain free fatty acids accumulated at the onset of ischemia. J Neurochem 47: 123-132
19. Israel M, Lesbats B (1982) Application to mammalian tissues of the chemiluminescent method for detecting acetylcholine. J Neurochem 39:248-250
20. Janssens D, Michiels C, Delaive E, Fliaers F, Drieu K, Remacle J (1995) Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide. Biochem Pharmacol 50:991-999
21. Karcher L, Zagermann P, Krieglstein J (1984) Effect of an extract of Ginkgo biloba on rat brain energy metabolism in hypoxia. Naunyn-Schmiedeberg's Arch Pharmacol 327:31-35
22. Katayama Y, Kawamata T, Maeda T, Ishikawa K, Tsubokawa T (1994) Inhibition of the early phase of free fatty acid liberation during cerebral ischemia by excitatory amino acid antagonist administered by microdialysis. Brain Res 635:331-334
23. 2 and C activation during ischemia. J Neurochem 61:1677-1684
24. 2 in brain cortical cultures. Biochem J 310:83-90
25. Klein J, Köppen A, Löffelholz K, Schmitthenner J (1992) Uptake and metabolism of choline by rat brain after acute choline administration. J Neurochem 58:870-876
26. Klein J, Gonzalez R, Köppen A, Löffelholz K (1993) Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 22:293-300
27. Klein J, Chatterjee SS, Löffelholz K (1997) Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res 755: 347-350
28. Klein J, Vakil M, Bergman F, Holler T, Iovino M, Löffelholz K (1998) Glutamatergic activation of hippocampal phospholipase D: postnatal fading and receptor desensitization. J Neurochem 70:1679-1685
29. 2 are resistant to MPTP neurotoxicity. J Neurochem 71:2634-2637
30. Lazarewicz JW, Salinska E (1995) N-methyl-D-aspartate-evoked release of cyclooxygenase products in rabbit hippocampus: an in vivo microdialysis study. J Neurosci Res 40:660-666
31. Lazarewicz JW, Wroblewski JT, Palmer ME, Costa E (1988) Activation of N-methyl-D-aspartate-sensitive receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 27:765-769
32. 2: variation of the substituents in positions 1, 3, and 5. J Med Chem 40:3381-3392
33. Löscher W (1997) Animal models of intractable epilepsy. Prog Neurobiol 53:239-258
34. 2. Proc Natl Acad Sci USA 94: 6500-6505
35. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992) Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89:1671-1675
36. Oberpichler H, Sauer D, Rossberg C, Mennel HD, Krieglstein J (1990) PAF-antagonist ginkgolide B reduces postischemic neuronal damage in rat brain hippocampus. J Cereb Blood Flow Metab 10:133-135
37. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press, San Diego
38. Pellerin L, Wolfe LS (1991) Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus. Neurochem Res 16:983-989
39. Racine RJ (1972) Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32:281-294
40. Rodriguez De Turco EB, Droy-Lefaix MT, Bazan NG (1993) Decreased electroconvulsive-shock-induced diacylglycerol and free fatty acid accumulation in the rat brain by Ginkgo biloba extract (EGb 761): selective effect in hippocampus as compared with cerebral cortex. J Neurochem 61:1438-1444
41. 2) activity in gerbil brain: enhanced activities of cytosolic, mitochondrial, and microsomal forms after ischemia and reperfusion. J Neurosci 11:1829-1836
42. Rothman SM, Olney JW (1995) Excitotoxicity and the NMDA receptor: still lethal after eight years. Trends Neurosci 18:299-302
43. Sanfeliu C, Hunt A, Patel AJ (1990) Exposure to N-methyl-D-aspartate increases release of arachidonic acid in primary cultures of rat hippocampal neurons and not in astrocytes. Brain Res 526:241-248
44. Santiago M, Westerink BHC (1990) Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes. Naunyn-Schmiedeberg's Arch Pharmacol 342:407-414
45. 2 is activated after experimental closed head injury in the rat. J Neurochem 53:1541-1546
46. Vanicky I, Marsala M, Yaksh TL (1998) Neurodegeneration induced by reverse microdialysis of NMDA: a quantitative model for excitotoxicity in vivo. Brain Res 789:347-350
47. Zapata A, Capdevila JL, Trullas R (1998) Region-specific and calcium-dependent increase in dialysate choline levels by NMDA. J Neurosci 18:3597-3605